Suprachoroidal Tyrosinase Therapy of Neovascular AMD

Retina Synthesis - A podcast by Retina Synthesis

Categories:

We discuss the use of a suprachoroidal delivery system for delivery of tryrosinase kinase inhibitor for the treatment of neovascular AMD with Dr. Thomas Ciulla, Chief Development Officer, Chief Medical Officer, Clearside Biomedical.

Visit the podcast's native language site